Citations

Showing 10 of 108119 citations.

Surgical Correction of Adult Congenital Penile Curvature: A Systematic Review
Britton, Cameron J. , Jefferson, Francis A. , Sharma, Vidit , Hernandez, J. Clavell, Levine, Laurence A. , Ziegelmann, Matthew , Ziegelmann, Matthew J, Findlay, Bridget L.

Mayo Clinic

The Journal of Sexual Medicine | January 5, 2022 | Volume: 19 | Issue: 2 | Pages: 364-376

10.1016/j.jsxm.2021.11.017 | PMID 34996726 Get It

ABSTRACTBackgroundCongenital penile curvature (CPC) is corrected surgically by various corporoplasty or tunica albuginea plication techniques, but the optimal surgical approach is not well-defined.AimTo provide a comprehensive evaluation of the published literature pertaining to outcomes with penile plication and corporoplasty techniques for surgical management of CPC. To determine if plication or corporoplasty offers superior outcomes in surgical correction of CPC.MethodsA systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Checklist. The following databases were queried from inception to March 18, 2020 to search for studies describing surgical treatment of CPC: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily, Ovid Embase, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus.OutcomesObjective and subjective postoperative outcomes including penile straightening, shortening, penile sensory changes, and reoperation rates for both corporoplasty and tunica albuginea plication were summarized.ResultsFifty-five articles comprising 2,956 patients with CPC who underwent a plication procedure (n = 1,375) or corporoplasty (n = 1,580) were included. The definition of “treatment success” varied widely and most often involved subjective patient reporting (22 studies; 40%) or objective assessment (15 studies; 27%). We considered curvature correction to be satisfactory if there was self-reported patient satisfaction or residual curvature after correction of <20˚. Reported rates of successful straightening ranged from 75 to 100% and 73 to 100% for plication and corporoplasty, respectively. A comprehensive and accurate assessment of surgical outcomes for CPC correction, such as satisfactory penile straightening, reoperation rates, glans sensory changes, and other complications was limited by significant inter-study heterogeneity with respect to the reporting of treatment outcomes.Clinical ImplicationsWhile both plication and corporoplasty appear to be safe and effective options in the treatment of CPC, definitive conclusions cannot be drawn with respect to treatment superiority due to low-quality study design, methodology flaws, and significant heterogeneity in reporting.Strength & LimitationsThis report represents the most comprehensive review of CPC surgical management. However, there is a significant lack of standardization in the reporting of treatment outcomes for CPC, thereby limiting the reliability of the published data summarization encompassed by our review.ConclusionBoth plication and corporoplasty demonstrate high success rates and relatively low complication rates in the treatment of CPC, albeit with low-level evidence available in most research publications. Robust comparison of the surgical techniques used to correct CPC is limited by significant variation in reporting methods used in the literature.
Planning a Change Easily (PACE) for smokers who are not ready to quit: a telephone‐based, randomized controlled trial
Derefinko, Karen J. , Bursac, Zoran , Hand, Sarah , Ebbert, Jon O. , Womack, Catherine, Klesges, Robert C.

Mayo Clinic

Addiction | January 5, 2022 | Volume: 117 | Issue: 6 | Pages: 1748-1757

10.1111/add.15796 | PMID 34985171 Get It

AbstractAimsTo compare brief advice (BA), motivational interviewing (MI), rate reduction (RR), and combined MI and RR (MI + RR) to promote smoking cessation in smokers not ready to quit.DesignRandomized controlled trial with four parallel groups of smoking cessation intervention. Participants were randomly assigned 1:2:2:2 to receive one of the following interventions: BA (n = 128), MI (n = 258), RR (n = 257), and MI + RR (n = 260).SettingThe United States. All participant contact occurred over the telephone to be consistent with the typical quit line format.ParticipantsA total of 903 adult smokers. Participants had a mean age of 49 (SD = 13.3) years and were 28.9% male and 63.3% Caucasian.InterventionsThe BA group received advice similar to typical smoking cessation quit lines. The MI group received advice using basic MI principles to elicit language that indicates behavioral change. The RR group received behavioral skills training and nicotine gum. The MI + RR group combined elements of MI and RR conditions. All interventions were six sessions.MeasurementsThe primary outcome measure was self‐reported point prevalence at 12 months. The secondary outcome was self‐reported prolonged abstinence at 12 months.FindingsIntention to treat (ITT) point prevalence at 12 months indicated that BA (10.9%) had significantly lower point prevalence rates than RR (27.2%, OR = 3.17, 1.69–5.94), and MI + RR (26.9%, OR = 3.16, 1.68–5.93). BA did not have a significantly lower point prevalence rate than MI (15.5%, OR = 1.56, 95% CI = 0.81–3.02).ConclusionsThis randomized controlled trial provided evidence that rate reduction, which offers structured behavioral skills and nicotine gum, either alone or combined with motivational interviewing, is the most effective form of cessation intervention for smokers not ready to quit.
Establishing the Groundwork for Clinical Trials With Hiccupops ® for Hiccup Palliation
Ehret, Christopher , Jatoi, Aminah , Ehret, Christopher J

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | January 5, 2022 | Volume: 39 | Issue: 10 | Pages: 1210-1214

10.1177/10499091211063821 | PMID 34985350 Get It

Objective Because hiccup palliation remains an unmet clinical need, we report here on an early experience with Hiccupops, ® a patented product designed for the express purpose of providing a mechanism-based intervention for hiccup palliation. Methods Meter Health, the developer and manufacturer of this patented product, used a purposive sampling approach to allow individuals with hiccups and a desire for hiccup palliation to purchase their agent and then to report on its efficacy or lack thereof. The authors of this report were provided these outcome data and allowed to analyze, report, and publish with no input from Meter Health with the exception of comments on accuracy. Results This report focused on 43 surveys that were completed. In response to the question, “Did the Hiccupops work for the person they were purchased for?” 29 (67%) responded, “yes.” Seven individuals (16%) responded, “no;” and 7 (16%) were “not sure.” Write-in comments appeared to substantiate the effective palliative nature of the intervention: “A friend with 10 days of hiccups following… brain tumor surgery, after 2 days, they stopped!!!#.” Another noted the following: “I like that if my hiccups get painful they’re there as a quick relief.” Less favorable comments were also noted: “She couldn’t get past the…. taste.” Another read as follows: “They were not effective in stopping my father’s intractable hiccups…. I like that there is someone out there who cares about trying to stop people’s hiccups.” Conclusions This patented product appears to palliate hiccups in some individuals and merits further study.
Systematic review and meta‐analysis of the outcome of puborectalis division in the treatment of anismus
Barsom, Samer Hani, Khan, Sualeh Muslim , Wexner, Steven D. , Emile, Sameh Hany , Khan, Sualeh Muslim , Wexner, Steven D

Mayo Clinic

Colorectal Disease | January 5, 2022 | Volume: 24 | Issue: 4 | Pages: 369-379

10.1111/codi.16040 | PMID 34984814 Get It

AbstractAimAnismus is a common cause of obstructed defaecation syndrome (ODS). The aim of the present review is to assess the efficacy and safety of puborectalis muscle (PRM) division in the treatment of anismus.MethodPubMed, Scopus, Web of Science and the Cochrane Library were searched for studies that assessed the outcome of PRM division in the treatment of anismus. The main outcome measures were subjective improvement in ODS, decrease in the Wexner constipation score and ODS score, and complications, namely faecal incontinence (FI).ResultsTen studies (204 patients, 63.7% male) were included. The weighted mean rate of initial subjective improvement across randomized trials was 97.6% (95% CI 94%–100%) and across nonrandomized studies it was 63.1 (95% CI 39.3%–87%). The weighted mean rate of 12‐month improvement across randomized trials was 64.9% (95% CI 53.3%–76.4%) and across nonrandomized studies it was 55.9% (95% CI 30.8%–81%). The weighted mean rate of FI across randomized trials was 12.1% (95% CI 4.2%–20%) and across nonrandomized studies it was 10.4% (95% CI 1.6%–19.3%). Male sex and unilateral PRM division were significantly associated with recurrence of symptoms after PRM division. Bilateral PRM division, posterior division, complete division and concomitant sphincterotomy were significantly associated with FI after PRM division.ConclusionsThe use of PRM division for treatment of anismus was followed by some initial improvement in ODS symptoms which decreased to <60% 12 months after PRM division. The mean rate of FI after PRM division, namely 10%–12%, is a limitation of the technique. Further well‐designed trials are needed to verify the outcome of PRM division in the treatment of anismus.
Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids
Smirnova, Ekaterina , Puri, Puneet , Chalasani, Naga , Shah, Vijay H. , Taylor, Stephanie , Mirshahi, Faridoddin , Muthiah, Mark D , Smirnova, Ekaterina , Chalasani, Naga , Kiani, Calvin , Sanyal, Arun J.

Mayo Clinic

Hepatology Communications | January 5, 2022 | Volume: 6 | Issue: 5 | Pages: 1073-1089

10.1002/hep4.1885 | PMID 34984859 Get It

The perturbations in bile acids (BAs) in alcohol‐associated hepatitis (AH) and its relationship to disease severity is not well defined. The aims of this study were to define (1) the effects of heavy alcohol consumption on BAs and related microbiome, (2) the additional changes with AH, and (3) the relationship of these changes to disease severity. In this multicenter study, plasma and fecal BAs and related microbiome were interrogated in healthy individuals, heavy drinking controls (HDCs) without overt liver disease, and AH. Compared to healthy controls, HDCs had increased glycine‐conjugated 7α and 27α primary BAs and increased secondary BA glycocholenic sulfate (multiple‐comparison adjusted P < 0.05 for all). Plasma‐conjugated cholic and chenodeoxycholic acid increased in AH along with the secondary BAs ursodeoxycholic and lithocholic acid (P < 0.001 for all), whereas deoxycholic acid decreased; however fecal concentrations of both deoxycholic acid and lithocholic acid were decreased. Glycocholenic acid further increased significantly from HDCs to AH. HDCs and AH had distinct plasma and fecal BA profiles (area under the curve, 0.99 and 0.93, respectively). Plasma taurochenodeoxycholic acid and tauroursodeoxycholic acid were directly related to disease severity, whereas fecal ursodeoxycholic acid was inversely related. The fecal abundance of multiple taxa involved in formation of secondary BAs, especially deoxycholic acid (Clostridium cluster XIVa) was decreased in AH. Multiple genera containing taxa expressing 3α, 3β, 7α, and 7β epimerases were decreased with concordant changes in fecal BAs that required these functions for formation. Conclusion: There are distinct changes in BA‐transforming microbiota and corresponding BAs in AH that are related to disease severity.
Persistent foramen of Huschke: Presentation, evaluation, and management
Macielak, Robert J. , Nassiri, Ashley M. , Fillmore, W. Jonathan , Lane, John I. , Driscoll, Colin L. W., Carlson, Matthew L.

Mayo Clinic

Laryngoscope Investigative Otolaryngology | January 5, 2022 | Volume: 7 | Issue: 1 | Pages: 237-241

10.1002/lio2.725 | PMID 35155803 Get It

AbstractObjectiveDescribe the presentation and management strategy for patients with symptomatic foramen of Huschke (FH).PatientsAdults with persistent FH confirmed on imaging.InterventionsDiagnosis and management of symptomatic persistent FH.Main outcome measureResolution of otologic symptoms.ResultsA total of four patients with symptomatic, radiographically‐confirmed persistent FH were included. The majority of patients endorsed otalgia (n = 4) and otorrhea (n = 3), and only one patient was noted to have a conductive hearing loss. All patients were noted to have dynamic movement of an external auditory canal mass with mandible manipulation on examination, and all patients had an identifiable fistula on imaging. Patients underwent surgical intervention, including both preauricular (n = 2) and transcanal (n = 2) approaches, and all endorsed symptomatic resolution after convalescence.ConclusionsPersistent FH remains an uncommon and potentially underrecognized cause of otologic symptoms. Diagnosis requires a high index of suspicion, and one must rely on both key examination findings and imaging to confirm this diagnosis. In appropriately selected patients, surgical intervention can provide durable symptomatic resolution.Level of evidenceIV
A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act
Reihl, Sheantel , Patil, Nirav , Morshed, Ramin A, Mehari, Mulki, Aabedi, Alexander, Chukwueke, Ugonma N, Porter, Alyx B, Fontil, Valy , Cioffi, Gino, Waite, Kristin, Ostrom, Quinn, Barnholtz-Sloan, Jill, Hervey‐Jumper, Shawn L. , Ostrom, Quinn T. , Morshed, Ramin A. , Reihl, Sheantel J , Kruchko, Carol , Hervey-Jumper, Shawn L , Morshed, Ramin , Patil, Nirav , Mehari, Mulki, Aabedi, Alexander, Chukwueke, Ugonma N, Porter, Alyx B, Fontil, Valy , Cioffi, Gino, Waite, Kristin, Barnholtz-Sloan, Jill, Ostrom, Quinn T

Mayo Clinic

Neuro-Oncology | January 5, 2022 | Volume: 24 | Issue: 8 | Pages: 1341-1349

10.1093/neuonc/noac011 | PMID 34999844 Get It

Abstract Background The NIH Revitalization Act, implemented 29 years ago, set to improve the representation of women and minorities in clinical trials. In this study, we investigate progress made in all phase therapeutic clinical trials for neuroepithelial CNS tumors stratified by demographic-specific age-adjusted disease incidence and mortality. Additionally, we identify workforce characteristics associated with clinical trials meeting established accrual benchmarks. Methods Registry study of published clinical trials for World Health Organization defined neuroepithelial CNS tumors between January 2000 and December 2019. Study participants were obtained from PubMed and ClinicalTrials.gov. Population-based data originated from the CBTRUS for incidence analyses. SEER-18 Incidence-Based Mortality data was used for mortality analysis. Descriptive statistics, Fisher exact, and χ 2 tests were used for data analysis. Results Among 662 published clinical trials representing 49 907 participants, 62.5% of participants were men and 37.5% women (P &lt; .0001) representing a mortality specific over-accrual for men (P = .001). Whites, Asians, Blacks, and Hispanics represented 91.7%, 1.5%, 2.6%, and 1.7% of trial participants. Compared with mortality, Blacks (47% of expected mortality, P = .008), Hispanics (17% of expected mortality, P &lt; .001) and Asians (33% of expected mortality, P &lt; .001) were underrepresented compared with Whites (114% of expected mortality, P &lt; .001). Clinical trials meeting accrual benchmarks for race included minority authorship. Conclusions Following the Revitalization Act, minorities and women remain underrepresented in therapeutic clinical trials for neuroepithelial tumors, relative to disease incidence and mortality. Study accrual has improved with time. This study provides a framework for clinical trial accrual efforts and offers guidance regarding workforce considerations associated with enrollment of underserved patients.
Associations Between Physician Continuous Professional Development and Referral Patterns: A Systematic Review and Meta-Analysis
Cook, David A. , Stephenson, Christopher R. , Pankratz, V. Shane , Wilkinson, John M. , Maloney, Stephen , Prokop, Larry J. , Foo, Jonathan , Pankratz, V. Shane , Maloney, S , Foo, J , Prokop, Larry , Cook, D A , Stephenson, Christopher R , Wilkinson, John M

Mayo Clinic

Academic Medicine | January 5, 2022 | Volume: 97 | Issue: 5 | Pages: 728-737

10.1097/acm.0000000000004575 | PMID 34985042 Get It

Abstract Purpose Both overuse and underuse of clinician referrals can compromise high-value health care. The authors sought to systematically identify and synthesize published research examining associations between physician continuous professional development (CPD) and referral patterns. Method The authors searched MEDLINE, Embase, PsycInfo, and the Cochrane Database on April 23, 2020, for comparative studies evaluating CPD for practicing physicians and reporting physician referral outcomes. Two reviewers, working independently, screened all articles for inclusion. Two reviewers reviewed all included articles to extract information, including data on participants, educational interventions, study design, and outcomes (referral rate, intended direction of change, appropriateness of referral). Quantitative results were pooled using meta-analysis. Results Of 3,338 articles screened, 31 were included. These studies enrolled at least 14,458 physicians and reported 381,165 referral events. Among studies comparing CPD with no intervention, 17 studies with intent to increase referrals had a pooled risk ratio of 1.91 (95% confidence interval: 1.50, 2.44; P &lt; .001), and 7 studies with intent to decrease referrals had a pooled risk ratio of 0.68 (95% confidence interval: 0.55, 0.83; P &lt; .001). Five studies did not indicate the intended direction of change. Subgroup analyses revealed similarly favorable effects for specific instructional approaches (including lectures, small groups, Internet-based instruction, and audit/feedback) and for activities of varying duration. Four studies reported head-to-head comparisons of alternate CPD approaches, revealing no clear superiority for any approach. Seven studies adjudicated the appropriateness of referral, and 9 studies counted referrals that were actually completed (versus merely requested). Conclusions Although between-study differences are large, CPD is associated with statistically significant changes in patient referral rates in the intended direction of impact. There are few head-to-head comparisons of alternate CPD interventions using referrals as outcomes.
Autoimmune gastrointestinal dysmotility following SARS‐CoV‐2 infection successfully treated with intravenous immunoglobulin
Montalvo, Mayra , Nallapaneni, Padmini, Hassan, Sara , Pittock, Sean J. , Khlevner, Julie , Nurko, Samuel , Pittock, S J , Nurko, Samuel

Mayo Clinic

Neurogastroenterology & Motility | January 5, 2022 | Volume: 34 | Issue: 7 | Pages: No page available

10.1111/nmo.14314 | PMID 34984765 Get It

AbstractBackgroundAutoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia that can be paraneoplastic or idiopathic. Some presentations can be preceded by a viral infection.MethodsWe report a case of a 17‐year‐old girl that developed intractable nausea and early satiety after SARS‐CoV‐2 infection.Key resultsOver ten months, she required nasogastric and nasoduodenal tube feedings and finally was advanced to total parenteral nutrition to meet her caloric needs. Her α3 nicotinic ganglionic acetylcholine and anti‐striational antibodies were mildly elevated.Gastrointestinal transit scintigraphy studies showed delayed gastric emptying and slowed small bowel transit. Thermoregulatory sweat test showed areas of anhidrosis consistent with autonomic sudomotor impairment. After IVIG treatment the patient's symptoms improved dramatically and she was able to tolerate full oral diet. This was reflected by improvement of her baseline transit studies and the thermoregulatory sweat test.Conclusions and inferencesThis is the first report of AGID occurring after SARS‐CoV‐2 infection. The dramatic response to IVIG emphasizes the importance of early recognition and the reversible and treatable nature of this condition.
Health Screening Program to Enhance Enrollment of Women and Minorities in CREST-2
Lal, Brajesh K., Meschia, James F., Jones, Michael , Aronow, Herbert D., Mirzoca, Angelica R. , Lake, Rachel , Howard, George, Brott, Thomas G., Lackey, Angelica , Lal, Brajesh K., Meschia, James F., Jones, Michael , Aronow, Herbert D., Lake, Rachel , Howard, George, Brott, Thomas G.

Mayo Clinic

Stroke | January 5, 2022 | Volume: 53 | Issue: 2 | Pages: 355-361

10.1161/strokeaha.120.033226 | PMID 34983242 Get It

Background and Purpose: The CREST-2 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial) consists of 2 parallel randomized stroke prevention trials in patients with asymptomatic high-grade stenosis of the cervical carotid artery. The purpose of this report is to detail the outcomes of a health screening effort to increase trial enrollment of women and minorities. Methods: Life Line screening (LLS) conducts nationwide screening for vascular disease. Screenings within a 50-mile radius of each CREST-2 center were identified for participation in a joint CREST-LLS program over the course of one year (November 2018 to October 2019) whereby patients with an abnormal carotid ultrasound were referred to the local CREST-2 center for further workup, management, and potential consideration for trial enrollment. Results: LLS completed the screening of 588 198 individuals in 29 732 zip codes across the United States. Of those, 230 021 individuals were screened at events occurring near a CREST-2 clinical center and 646 (0.3%) were found to have abnormal carotid ultrasound findings. Each of the 646 individuals was contacted by CREST-LLS program staff for permission to be referred to their local CREST-2 center; 200 (31%) consented to be contacted by CREST-2. Of those, 39 (19.5%) agreed to be, and were, evaluated at their local CREST-2 center. High-grade stenosis was confirmed in 27 patients. A total of 3 patients were eligible for the trial and were enrolled, one woman but no racial/ethnic minorities. Conclusions: The LLS program appears to identify community-living individuals with high-grade carotid stenosis through ultrasonography. However, the prevalence of abnormal carotid findings was low. In addition, screening and offering participation into the CREST-2 trial had no substantial impact on the proportion of women and minorities enrolled in the trial. Additional innovative strategies are needed to promote enrollment of diverse patients with carotid stenosis into stroke prevention trials.